What is Ozone Therapy? Q & A

In Principles and Applications of Ozone Therapy (2011), Dr. Frank Shallenberger tells of his introduction to ozone therapy via the work of his predecessor, Dr. Charles Farr. In the 1980s, Dr. Farr began treating patients with Auto Immune Disease Syndrome (AIDS)—caused by the accumulation of molecules called oxidants—by injecting hydrogen peroxide, a powerful oxidant, directly into their veins. Dr. Farr’s success at alleviating symptoms such as fatigue, insomnia, brain fog, joint and muscle pain, and muscle weakness suggested that “the reason people get sick and diseased as they get older might have something to do with how they utilize and process oxygen” (Shallenberger, 2011).

The following Q & A is intended provide an introduction to ozone, and the various ozone therapies our clinic provides:

Q: What is ozone?

A: Consisting of three oxygen (O2) atoms that share a common electron, ozone (O3) is a naturally occurring molecule—called an oxidant—in the earth’s atmosphere.

Q: What is ozone therapy?

A: Working in a manner similar to vaccines that promote the production of viral antibodies, ozone therapy stimulates the formation of oxidants in the blood, essentially training the body to utilize them efficiently.

Q: How is ozone administered?

A: There are three administration techniques for ozone therapy. The first, called an Ozone Sauna, involves the patient entering a hyperbaric chamber into which heated ozone is pumped. The heat causes the patient to perspire, while the ozone promotes the formation of oxidants in the blood that the body must then dispose of. When someone says they are “sweating it out,” this is the technique to which they are referring.

The second option, called minor-Auto-Hemo-therapy (mAH), involves the blood being drawn out of the body, mixed with ozone, and then injected directly into the treatment site, while the third option administers blood-ozone intravenously, and is referred to as Major-Auto-Hemo-therapy (MAH).

Q: What conditions can ozone therapy treat?

A: Here at Restorative Health Clinic, we offer ozone therapy for patients with Lyme disease, chronic fatigue syndrome (CFS), and the chronic infections typically related to such illnesses. Essentially, any condition that impairs the body’s natural immunity can be treated with ozone, as it stimulates auto-immune defense mechanisms, necessary for tissue and cellular repair.

Q: How do I know if ozone therapy is right for me?

A: Consult your physician regarding the potential benefits and appropriate administration method for your particular condition. Dr. Vosloo and Dr. Hatlestad look forward to providing their guidance to anyone looking to improve their health and vitality.

If you would like to schedule an appointment, please give us a call at 503.747.2021.

Prostate Health Awareness Month

Researchers say a cheap, generic pill called finasteride (Propecia, Proscar) prevents almost 40 percent of low-grade prostate cancers without increasing the risk of dying from more aggressive tumors.

Finasteride is known as a 5-alpha reductase inhibitor, which means that it blocks the conversion of testosterone to dihydrotestosterone (DHT). DHT is the primary contributing factor in male pattern baldness. DHT plays a role in the development and exacerbation of benign prostatic hyperplasia, as well as prostate cancer, by enlarging the prostate gland.

There are, however,  natural occurring 5-alpha reductase inhibitors that can be combined to effectively reduce this conversion of testosterone to DHT. The possible side effects are minimized with our complete holistic  approach. At Restorative Health Clinic we specialize in Men’s Health and proper Hormone Optimization. Please contact us for complete information.


Finasteride May Safely Lower Prostate Cancer Risk.

USA Today  (8/15, Szabo) reports that in a study funded by the National Cancer Institute and published in The New England Journal of Medicine, investigators found that “among men getting screened with the PSA, those randomly assigned to take the drug finasteride for seven years were 30% less likely to be diagnosed with prostate cancer.” Researchers also found that participants taking finasteride had a 43% lower risk of being “diagnosed with a ‘low-grade’ prostate cancer – the kind most likely to lead to unnecessary treatment.”

The New York Times  (8/15, Parker-Pope) “Well” blog reports that the medication has not approved the medication to prevent prostate cancer because research indicated that while it “clearly reduced the overall risk for prostate cancer, slightly more men who used the drug developed fast-growing tumors compared with men who took a placebo.” The new data suggest that finasteride “was not causing the aggressive tumors,” but was “more likely…reducing the size of a man’s prostate,” thus making it easier for aggressive tumors to be found.

The AP  (8/15, Marchione) reports that the findings “could prompt a fresh look at using” finasteride to prevent cancer, with some “experts say[ing] it could prevent tens of thousands of cases each year.”






Pin It on Pinterest